Alembic Pharma received USFDA approval for diabetes drug

Posted on:17 Oct 2018 11:27:42
Alembic Pharma received USFDA approval for diabetes drug
17 October 2018 Current Affairs:

Alembic Pharmaceuticals received a tentative approval from the United States Food and Drug Administration (USFDA), the U.S. health regulator for its Alogliptin tablets. The drug is used for the treatment of type 2 diabetes.
 The Alogliptin tablets are made in the strengths of 6.25 mg, 12.5 mg and 25mg. The product is a generic version of Takeda Pharms USA’s Nesina tablets.

Alembic Pharmaceuticals received a tentative approval from the United States Food and Drug Administration (USFDA), the U.S. health regulator for its Alogliptin tablets. The drug is used for the treatment of type 2 diabetes.
 The Alogliptin tablets are made in the strengths of 6.25 mg, 12.5 mg and 25mg. The product is a generic version of Takeda Pharms USA’s Nesina tablets.




Daily Current Affairs Videos Video Link
25th April 2019 Current Affairs Video
24th April 2019 Current Affairs Video
23rd April 2019 Current Affairs Video
22nd April 2019 Current Affairs Video
20th April 2019 Current Affairs Video
Watch more Current Affairs Videos



Monthly Current Affairs

Fresherslive telegram Group

Current Affairs Section

Daily Current Affairs Quiz


Subscribe to Current Affairs

Enter your email to get daily current affairs
SUBSCRIBE

Currentt Affairs 2019 April

25 APRIL
NEWS
24 APRIL
NEWS
23 APRIL
NEWS
22 APRIL
NEWS

Currentt Affairs 2019 March

31 MARCH
NEWS
30 MARCH
NEWS
29 MARCH
NEWS
28 MARCH
NEWS

Currentt Affairs 2019 February

28 FEBRUARY
NEWS
27 FEBRUARY
NEWS
26 FEBRUARY
NEWS
25 FEBRUARY
NEWS




×

₹ 249

₹ 1000

Only 10 days left !